HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

High-dose-rate remote brachytherapy for metachronous second primary carcinoma of soft palate by iridium 192 isotope in an afterload surface mold.

Abstract
Conservative management of metachronous second primary carcinoma of head and neck is preferred in order to preserve form and function. The purpose of the case report is to describe the treatment of metachronous second primary carcinoma of soft palate by high-dose-rate, remote, afterload brachytherapy. The brachytherapy was done in remote settings by afterloading Iridium 192 isotope carried through a custom fabricated surface mold. The mold enabled good adaptation, stability, and repeatable positioning of the radiation source at each treatment session of fractionated brachytherapy offering consistent dosimetric advantage through a single dosimetry calculation. Collaborative efforts of radiation oncologist and prosthodontist ensured conservative treatment in outpatient set up with minimal adverse effects.
AuthorsNallaiah Venkatraman P, Veena Jain, D N Sharma, Dheeraj Kumar Koli, Aditi Nanda, Arun Thimmarayappa
JournalSpecial care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry (Spec Care Dentist) Vol. 42 Issue 5 Pg. 536-540 (Sep 2022) ISSN: 1754-4505 [Electronic] United States
PMID35152444 (Publication Type: Case Reports)
Copyright© 2022 Special Care Dentistry Association and Wiley Periodicals LLC.
Chemical References
  • Isotopes
  • Iridium
Topics
  • Brachytherapy
  • Carcinoma, Squamous Cell (radiotherapy)
  • Humans
  • Iridium
  • Isotopes
  • Palate, Soft

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: